| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/09/2006 | US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 03/09/2006 | US20060052439 Salvinorin derivatives and uses thereof |
| 03/09/2006 | US20060052436 Pyrroloterpenes and use of the same as antimicrobial and anticancer agents |
| 03/09/2006 | US20060052418 Viral polymerase inhibitors |
| 03/09/2006 | US20060052411 Immunosuppressants, analgesics, antiinflammatory agents |
| 03/09/2006 | US20060052408 Cyclopropyl compounds as ccr5 antagonists |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052395 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 03/09/2006 | US20060052394 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 03/09/2006 | US20060052392 Isoindoline derivative |
| 03/09/2006 | US20060052384 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 03/09/2006 | US20060052379 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
| 03/09/2006 | US20060052374 Amino-tetrazole analogues and methods of use |
| 03/09/2006 | US20060052366 Pyridine derivatives as fungicidal compounds |
| 03/09/2006 | US20060052365 Protease inhibitors |
| 03/09/2006 | US20060052358 Modulators of ATP-binding cassette transporters |
| 03/09/2006 | US20060052345 Quinazolinone compounds as calcilytics |
| 03/09/2006 | US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 03/09/2006 | US20060048696 Methods of crystal precipitation |
| 03/09/2006 | CA2579078A1 Cyclopamine analogues and methods of use thereof |
| 03/09/2006 | CA2578955A1 Isoindolin-1-one derivatives |
| 03/09/2006 | CA2578630A1 Pyrimidinylimidazoles as tgf-beta inhibitors |
| 03/09/2006 | CA2578628A1 Pyrimidinylpyrazoles as tgf-beta inhibitors |
| 03/09/2006 | CA2578604A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | CA2577398A1 Urea derivatives as calcium channel blockers |
| 03/09/2006 | CA2577275A1 Quinazolinone derivatives and their use as b-raf inhibitors |
| 03/09/2006 | CA2576973A1 Benzamide compounds |
| 03/09/2006 | CA2576717A1 Pyrrole derivatives, their preparation and their therapeutic use |
| 03/09/2006 | CA2571989A1 Modulators of nuclear receptors |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1632479A2 Piperazine derivatives useful as ccr5 antagonists |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1632228A1 Medicinal composition containing triazole compound |
| 03/08/2006 | EP1631568A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 03/08/2006 | EP1631562A1 Chromene derivatives as anti-inflammatory agents |
| 03/08/2006 | EP1631561A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid |
| 03/08/2006 | EP1631560A2 C-fms kinase inhibitors |
| 03/08/2006 | EP1631551A2 Isoquinoline derivatives and their use as gfat inhibitors |
| 03/08/2006 | EP1631549A2 3-[2-(3-amino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 03/08/2006 | EP1631546A1 Sustituted indoline and indole derivatives |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1631286A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 03/08/2006 | EP1631285A1 Therapeutic agents useful for treating pain |
| 03/08/2006 | EP1631143A1 Hydrazone derivatives for combatting harmful insects and arachnids |
| 03/08/2006 | EP1406628B1 Tetrahydroquinoline derivatives |
| 03/08/2006 | EP1387841B1 Novel azole or triazole derivatives, method for preparing the same and use thereof as fungicides |
| 03/08/2006 | EP1349853B1 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections |
| 03/08/2006 | EP1339723B1 Process and ester derivatives useful for preparation of cephalosporins |
| 03/08/2006 | EP1330654B1 Acid-labile isotope-coded extractant (alice) in mass spectometric analysis |
| 03/08/2006 | EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/08/2006 | EP1276722B1 Naphthamidine urokinase inhibitors |
| 03/08/2006 | EP1178967B1 Quinoline derivatives as inhibitors of mek enzymes |
| 03/08/2006 | EP1176959B1 Novel prolines as antimicrobial agents |
| 03/08/2006 | EP0948327B1 Antidiabetic agents |
| 03/08/2006 | EP0938476B1 Process for substituted pyridines |
| 03/08/2006 | EP0891330B1 Substituted phenyl keto enols as pesticides and herbicides |
| 03/08/2006 | CN1745078A Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 03/08/2006 | CN1745077A 促旋酶抑制剂及其用途 Gyrase inhibitors and their use |
| 03/08/2006 | CN1745076A Malonamide derivatives as gamma-secretase inhibitors |
| 03/08/2006 | CN1745074A 5-HT receptor ligands and uses thereof |
| 03/08/2006 | CN1745065A 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as aspartic specifity cysteine proteinase inhibitors |
| 03/08/2006 | CN1744895A N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 03/08/2006 | CN1744894A 3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitor for the treatment of cancer |
| 03/08/2006 | CN1743315A 2-substituted-4,4,5,5-tetramethyl-1-hydroxyimidazoline, and its synthesis and use |
| 03/08/2006 | CN1244578C Substituted benzofuran-2-carboxamides derivatives |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244573C Benzofuran category compound, its preparing method and usage |
| 03/08/2006 | CN1244569C C-10 position taxane derivative and its medicine composition |
| 03/08/2006 | CN1244565C New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/07/2006 | US7009056 Glaucoma; multiple sclerosis |
| 03/07/2006 | US7009053 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 03/07/2006 | US7009052 such as 1-methyl-2-oxo-4-trifluoromethyl-1,2-dihydroquinoline-6-sulfonic acid phenylamide for use as androgen antagonists |
| 03/07/2006 | US7008952 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/07/2006 | US7008950 For example 3-(4-Isopropylphenyl)-5-(4-methoxybenzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran and its synthesis; suppress cell toxicities caused by beta-amyloid protein, protect nerve cells |
| 03/07/2006 | US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors |
| 03/07/2006 | US7008945 Amide derivatives |
| 03/07/2006 | US7008759 Dyes and use thereof in imaging members and methods |
| 03/02/2006 | WO2006023931A2 Kinase inhibitors |
| 03/02/2006 | WO2006023562A2 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2, 4-dione and analogues as inhibitors of macrophage elastase |
| 03/02/2006 | WO2006023467A1 3-SUBSTITUTED-5- AND 6-AMINOALKYL INDOLE-2-CARBOXYLIC ACID AMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Iϵ |
| 03/02/2006 | WO2006023462A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 03/02/2006 | WO2006023395A2 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors |
| 03/02/2006 | WO2006022773A1 Gyrase inhibitors and uses thereof |
| 03/02/2006 | WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity |
| 03/02/2006 | WO2006022374A1 2-phenylpyridine derivative |
| 03/02/2006 | WO2006021656A2 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 03/02/2006 | WO2006021544A1 2,4-di(aminophenyl) pyrimidines as plk inhibitors |
| 03/02/2006 | WO2006021448A1 Novel compounds having an anti-bacterial activity |
| 03/02/2006 | WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/02/2006 | WO2005075456A8 2-(piperidin-4-yl) -4, 5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors |
| 03/02/2006 | US20060046999 Monocyclic aroylpyridinones as antiinflammatory agents |
| 03/02/2006 | US20060046997 6-Alkenyl -, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 03/02/2006 | DE102004041163A1 Neue Verbindungen mit antibakterieller Aktivität New compounds with antibacterial activity |
| 03/02/2006 | CA2578168A1 2-phenylpyridine derivative |
| 03/02/2006 | CA2577061A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 03/02/2006 | CA2576063A1 Azo compounds and process for production thereof |
| 03/02/2006 | CA2575670A1 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 03/02/2006 | CA2574454A1 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 03/02/2006 | CA2573371A1 Pyrimidines as plk inhibitors |